C. Piazza
Chief Executive Officer at IGL Pharma, Inc.
Net worth: - $ as of 29/04/2024
Profile
C.
Richard Piazza was the founder of QSAM Biosciences, Inc. (founded in 2004) where he served as the Executive Chairman from 2020 to 2024.
He is currently the President & Chief Executive Officer of IGL Pharma, Inc. (since 2017) and the Chairman of NovaScan, Inc. (since 2018).
In the past, he held positions as the President & Chief Executive Officer of Maxia Pharmaceuticals, Inc. (2001-2002), VitaGen, Inc. (2002-2003), and TheraFuse, Inc. (2003-2004).
He also served as the Chief Executive Officer of SynVivo, Inc. (2014-2016) and as the Managing Director of Healthios Capital Markets LLC (2004-2007) and the Managing Partner of La Jolla Capital Partners, Inc. (2004-2007).
Additionally, he has held the title of Chairman at Chemokine Therapeutics Corp.
Dr. Piazza obtained a doctorate degree from the University of Leeds, a graduate degree from the State University of New York at Buffalo, and an undergraduate degree from The State University of New York.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 01/05/2024 | 0 ( -.--% ) | - $ | 29/04/2024 |
C. Piazza active positions
| Companies | Position | Start |
|---|---|---|
IGL Pharma, Inc.
 IGL Pharma, Inc. Medical/Nursing ServicesHealth Services IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX. | Chief Executive Officer | 31/12/2016 |
NovaScan, Inc.
 NovaScan, Inc. Medical SpecialtiesHealth Technology NovaScan, Inc. engages in the development of a technology that electrically images objects. Its technology measures the electrical properties of materials. The firm focuses on breast cancer detection. The company was founded in 2001 by Larry Wells and William Gregory and is headquartered in Chicago, IL. | Chairman | 31/10/2018 |
Former positions of C. Piazza
| Companies | Position | End |
|---|---|---|
| QSAM BIOSCIENCES, INC. | Founder | 01/05/2024 |
SynVivo, Inc.
 SynVivo, Inc. Packaged SoftwareTechnology Services SynVivo, Inc. is an American company that specializes in microfluidic organ-on-chip technology. The private company's platform allows for the real-time study of cellular behavior, drug delivery, and drug discovery. | Chief Executive Officer | 31/12/2015 |
| La Jolla Capital Partners, Inc. | Corporate Officer/Principal | 31/12/2006 |
Healthios Capital Markets LLC
 Healthios Capital Markets LLC Investment ManagersFinance Healthios Capital Markets LLC provides financial advisory services. The private company is based in Northbrook, IL and has subsidiaries in Thailand and Singapore. The company was founded by Fritz Reichenbach. | Corporate Officer/Principal | 31/12/2006 |
TheraFuse, Inc.
 TheraFuse, Inc. Medical SpecialtiesHealth Technology TheraFuse, Inc. designs and develops non-contact optical flow sensors for use in the commercial, industrial and medical applications. It offers delivery systems for insulin, pain medication, and protein drugs, disposable insulin patches for diabetics; and sprinkler hypodermic needles for sub-Q fluid delivery in drug pens. The company was founded in 2001 and is headquartered in Carlsbad, CA. | President | 31/08/2004 |
Training of C. Piazza
| The State University of New York | Undergraduate Degree |
| State University of New York at Buffalo | Graduate Degree |
| University of Leeds | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Chemokine Therapeutics Corp.
 Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Health Technology |
| La Jolla Capital Partners, Inc. | |
Healthios Capital Markets LLC
Healthios Capital Markets LLC Investment ManagersFinance Healthios Capital Markets LLC provides financial advisory services. The private company is based in Northbrook, IL and has subsidiaries in Thailand and Singapore. The company was founded by Fritz Reichenbach. | Finance |
TheraFuse, Inc.
TheraFuse, Inc. Medical SpecialtiesHealth Technology TheraFuse, Inc. designs and develops non-contact optical flow sensors for use in the commercial, industrial and medical applications. It offers delivery systems for insulin, pain medication, and protein drugs, disposable insulin patches for diabetics; and sprinkler hypodermic needles for sub-Q fluid delivery in drug pens. The company was founded in 2001 and is headquartered in Carlsbad, CA. | Health Technology |
VitaGen, Inc.
 VitaGen, Inc. Medical SpecialtiesHealth Technology VitaGen, Inc. develops and manufactures extracorporeal liver assisting devices. The company was founded in 1990 and is headquartered in La Jolla, CA. | Health Technology |
Maxia Pharmaceuticals, Inc.
 Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Commercial Services |
IGL Pharma, Inc.
IGL Pharma, Inc. Medical/Nursing ServicesHealth Services IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX. | Health Services |
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
NovaScan, Inc.
NovaScan, Inc. Medical SpecialtiesHealth Technology NovaScan, Inc. engages in the development of a technology that electrically images objects. Its technology measures the electrical properties of materials. The firm focuses on breast cancer detection. The company was founded in 2001 by Larry Wells and William Gregory and is headquartered in Chicago, IL. | Health Technology |
SynVivo, Inc.
SynVivo, Inc. Packaged SoftwareTechnology Services SynVivo, Inc. is an American company that specializes in microfluidic organ-on-chip technology. The private company's platform allows for the real-time study of cellular behavior, drug delivery, and drug discovery. | Technology Services |
- Stock Market
- Insiders
- C. Piazza
